STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

INVA ownership update — Bank of Nova Scotia reports 2,179,005 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bank of Nova Scotia filed an amended Schedule 13G reporting beneficial ownership of 2,179,005 shares of Innoviva, Inc. common stock, representing 3.37% of the class as of the reporting event date 09/30/2025. The filing shows the bank has sole voting and sole dispositive power over all reported shares and does not report shared voting or dispositive power. The filing identifies the filer as a parent holding company organized in Canada and includes a certification about comparable foreign regulatory oversight. No larger group affiliation, transfers on behalf of others, or ownership above 5% are reported.

Positive

  • Transparent disclosure of 2,179,005 shares and 3.37% stake
  • Sole voting and dispositive power reported for all shares, clarifying control
  • Filer identified as a parent holding company with certification of comparable foreign regulatory oversight

Negative

  • Position below 5%, so unlikely to trigger enhanced shareholder influence alone
  • No information provided about intent or any planned corporate actions involving the stake

Insights

Stake disclosure shows a non-controlling institutional holding of 3.37%.

The filing documents that Bank of Nova Scotia holds 2,179,005 shares with sole voting and sole dispositive power, which indicates direct control over voting and disposition decisions for this block of stock. The position is below the 5% reporting threshold typically associated with potentially activist or control intentions, so it is consistent with passive institutional ownership reporting.

Key near-term items to note include any subsequent amendments if the position changes above 5.00% or if the filer joins a group; such events would require different disclosure and could be material to investors within standard SEC reporting timeframes.

The filing indicates clear voting authority but no group affiliation or third-party holdings.

Since the filer reports sole voting and dispositive power for all 2,179,005 shares, governance implications are straightforward: the bank can vote this block without coordination reported here. The document also states the filer is a parent holding company organized in Canada, and it certifies comparable foreign regulatory oversight.

Investors may monitor for scheduled shareholder votes or corporate actions where a 3.37% stake could affect close outcomes; any change in voting power, disposition, or formation of a group would be disclosed in subsequent filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BANK OF NOVA SCOTIA
Signature:Raj Sachdeva
Name/Title:Vice President, Head of GBM&T, Compliance Canada
Date:10/08/2025

FAQ

What stake did Bank of Nova Scotia report in Innoviva (INVA)?

The filer reported beneficial ownership of 2,179,005 shares, equal to 3.37% of Innoviva's common stock.

Does the Bank of Nova Scotia have voting control over these INVA shares?

Yes, the filing states the bank has sole voting power and sole dispositive power for all 2,179,005 shares.

Is this ownership filing indicative of an activist stake in INVA?

No. The reported 3.37% position is below the common 5.00% threshold typically associated with potential activist intent; no group or intent is disclosed.

When was the Schedule 13G event date?

The date of the event requiring this filing is 09/30/2025, and the signature date is 10/08/2025.

What type of filer is Bank of Nova Scotia according to the filing?

The filing classifies the Bank of Nova Scotia as a parent holding company organized in Canada.
Innoviva

NASDAQ:INVA

INVA Rankings

INVA Latest News

INVA Latest SEC Filings

INVA Stock Data

1.62B
73.97M
0.98%
122.14%
10.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGAME